{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:47:31Z","timestamp":1790423251275,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006521","name":"STANFORD UNIVERSITY SCHOOL OF MEDICINE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006521","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1053\/j.ajkd.2023.01.447","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T18:15:34Z","timestamp":1679595334000},"page":"333-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Underdiagnosis of Primary Aldosteronism: A Review of Screening and Detection"],"prefix":"10.1053","volume":"82","author":[{"given":"Mario","family":"Funes Hernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1053\/j.ajkd.2023.01.447_bib1","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1681\/ASN.2008020225","article-title":"Mechanisms of ENaC regulation and clinical implications","volume":"19","author":"Bhalla","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2023.01.447_bib2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/physrev.1997.77.2.359","article-title":"Epithelial sodium channels: function, structure, and regulation","volume":"77","author":"Garty","year":"1997","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1053\/j.ajkd.2023.01.447_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/pr.115.011106","article-title":"Emerging roles of the mineralocorticoid receptor in pathology: toward new paradigms in clinical pharmacology","volume":"68","author":"Jaisser","year":"2016","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1053\/j.ajkd.2023.01.447_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"38","key":"10.1053\/j.ajkd.2023.01.447_bib5","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1093\/eurheartj\/ehac352","article-title":"Aldosterone in chronic kidney disease and renal outcomes [published correction appears in Eur Heart J. 2022;43(46):4814]","volume":"43","author":"Verma","year":"2022","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1053\/j.ajkd.2023.01.447_bib6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal outcomes in medically and surgically treated primary aldosteronism","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2023.01.447_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jama.1965.03090030022005","article-title":"Normokalemic primary aldosteronism. a detectable cause of curable \u201cessential\u201d hypertension","volume":"193","author":"Conn","year":"1965","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.ajkd.2023.01.447_bib8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2214\/ajr.179.4.1790825","article-title":"Screening for preclinical disease: test and disease characteristics","volume":"179","author":"Herman","year":"2002","journal-title":"AJR Am J Roentgenol"},{"issue":"9","key":"10.1053\/j.ajkd.2023.01.447_bib9","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1053\/j.ajkd.2023.01.447_bib10","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/HJH.0b013e32831286fd","article-title":"Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism","volume":"26","author":"Bernini","year":"2008","journal-title":"J\u00a0Hypertens"},{"issue":"3","key":"10.1053\/j.ajkd.2023.01.447_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/HYPERTENSIONAHA.108.114140","article-title":"Inappropriate left ventricular mass in patients with primary aldosteronism","volume":"52","author":"Muiesan","year":"2008","journal-title":"Hypertension"},{"issue":"8","key":"10.1053\/j.ajkd.2023.01.447_bib12","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.01.447_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1053\/j.ajkd.2023.01.447_bib14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.117.10596","article-title":"Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism patients at long term","volume":"71","author":"Rossi","year":"2018","journal-title":"Hypertension"},{"issue":"22","key":"10.1053\/j.ajkd.2023.01.447_bib15","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","article-title":"Long-term renal outcomes in patients with primary aldosteronism","volume":"295","author":"Sechi","year":"2006","journal-title":"JAMA"},{"issue":"8","key":"10.1053\/j.ajkd.2023.01.447_bib16","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1097\/HJH.0b013e328354f65b","article-title":"Plasma renin activity and the aldosterone-to-renin ratio are associated with the development of chronic kidney disease: the Ohasama Study","volume":"30","author":"Terata","year":"2012","journal-title":"J\u00a0Hypertens"},{"issue":"5","key":"10.1053\/j.ajkd.2023.01.447_bib17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/EJE-15-0450","article-title":"Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn\u2019s Registry","volume":"173","author":"Hanslik","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1053\/j.ajkd.2023.01.447_bib18","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1055\/s-0043-122887","article-title":"Primary aldosteronism and obstructive sleep apnea: is this a bidirectional relationship?","volume":"49","author":"Prejbisz","year":"2017","journal-title":"Horm Metab Res"},{"issue":"8","key":"10.1053\/j.ajkd.2023.01.447_bib19","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/HJH.0b013e3283492219","article-title":"Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population","volume":"29","author":"Sim","year":"2011","journal-title":"J\u00a0Hypertens"},{"issue":"8","key":"10.1053\/j.ajkd.2023.01.447_bib20","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/jhh.2009.96","article-title":"Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report","volume":"24","author":"Gaddam","year":"2010","journal-title":"J\u00a0Hum Hypertens"},{"issue":"10","key":"10.1053\/j.ajkd.2023.01.447_bib21","first-page":"1671","article-title":"The effects of eplerenone on the circadian blood pressure pattern and left ventricular hypertrophy in patients with obstructive sleep apnea and resistant hypertension-a randomized, controlled trial","volume":"8","author":"Krasi\u0144ska","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1053\/j.ajkd.2023.01.447_bib22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/jama.1964.03070160046009","article-title":"Plasma renin activity in primary aldosteronism. importance in differential diagnosis and in research of essential hypertension","volume":"190","author":"Conn","year":"1964","journal-title":"JAMA"},{"issue":"3","key":"10.1053\/j.ajkd.2023.01.447_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0002-9343(79)90786-1","article-title":"Reliability of screening methods for the diagnosis of primary aldosteronism","volume":"67","author":"Streeten","year":"1979","journal-title":"Am J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2023.01.447_bib24","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.7326\/0003-4819-66-6-1079","article-title":"Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism","volume":"66","author":"Kaplan","year":"1967","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2023.01.447_bib25","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"14","key":"10.1053\/j.ajkd.2023.01.447_bib26","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1053\/j.ajkd.2023.01.447_bib27","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1055\/s-0043-119755","article-title":"Is primary aldosteronism still largely unrecognized?","volume":"49","author":"Buffolo","year":"2017","journal-title":"Horm Metab Res"},{"issue":"9","key":"10.1053\/j.ajkd.2023.01.447_bib28","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study","volume":"167","author":"Brown","year":"2017","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1053\/j.ajkd.2023.01.447_bib29","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1210\/jc.2018-00617","article-title":"Cortisol excess in patients with primary aldosteronism impacts left ventricular hypertrophy","volume":"103","author":"Adolf","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1053\/j.ajkd.2023.01.447_bib30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/cen.14351","article-title":"Outcomes in unilateral primary aldosteronism after surgical or medical therapy","volume":"94","author":"Puar","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1053\/j.ajkd.2023.01.447_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1053\/j.ajkd.2023.01.447_bib32","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/SLA.0000000000003200","article-title":"The primary aldosteronism surgical outcome score for the prediction of clinical outcomes after adrenalectomy for unilateral primary aldosteronism","volume":"272","author":"Burrello","year":"2020","journal-title":"Ann Surg"},{"issue":"6","key":"10.1053\/j.ajkd.2023.01.447_bib33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/CIRCOUTCOMES.115.002002","article-title":"Cost-effectiveness of screening for primary aldosteronism and subtype diagnosis in the resistant hypertensive patients","volume":"8","author":"Lubitz","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"5","key":"10.1053\/j.ajkd.2023.01.447_bib34","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"17","key":"10.1053\/j.ajkd.2023.01.447_bib35","first-page":"e484","volume":"138","author":"Whelton","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"10.1053\/j.ajkd.2023.01.447_bib36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism\u2014the Japan Endocrine Society 2009","volume":"58","author":"Nishikawa","year":"2011","journal-title":"Endocr J"},{"issue":"3","key":"10.1053\/j.ajkd.2023.01.447_bib37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ando.2016.02.003","article-title":"SFE\/SFHTA\/AFCE consensus on primary aldosteronism, part 2: first diagnostic steps","volume":"77","author":"Douillard","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"issue":"12","key":"10.1053\/j.ajkd.2023.01.447_bib38","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1097\/HJH.0000000000001961","article-title":"2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH\/ESC Task Force for the Management of Arterial Hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J\u00a0Hypertens"},{"issue":"11","key":"10.1053\/j.ajkd.2023.01.447_bib39","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/jhh.2015.122","article-title":"Management of resistant hypertension: expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology","volume":"30","author":"Denolle","year":"2016","journal-title":"J\u00a0Hum Hypertens"},{"issue":"5","key":"10.1053\/j.ajkd.2023.01.447_bib40","first-page":"506","article-title":"Hypertension Canada\u2019s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children","volume":"34","author":"Nerenberg","year":"2018","journal-title":"Can J Cardiol"},{"issue":"5","key":"10.1053\/j.ajkd.2023.01.447_bib41","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","article-title":"Resistant Hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association","volume":"72","author":"Carey","year":"2018","journal-title":"Hypertension"},{"issue":"2","key":"10.1053\/j.ajkd.2023.01.447_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0001-2998(75)80033-X","article-title":"Radioimmunoassay of plasma renin activity","volume":"5","author":"Sealey","year":"1975","journal-title":"Semin Nucl Med"},{"issue":"2","key":"10.1053\/j.ajkd.2023.01.447_bib43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00004872-200402000-00023","article-title":"Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism","volume":"22","author":"Ferrari","year":"2004","journal-title":"J\u00a0Hypertens"},{"issue":"7","key":"10.1053\/j.ajkd.2023.01.447_bib44","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1210\/jc.2016-3851","article-title":"Effect of combined hormonal replacement therapy on the aldosterone\/renin ratio in postmenopausal women","volume":"102","author":"Ahmed","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1053\/j.ajkd.2023.01.447_bib45","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0025-6196(11)62105-8","article-title":"Validity of the aldosterone-renin ratio used to screen for primary aldosteronism","volume":"76","author":"Montori","year":"2001","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"10.1053\/j.ajkd.2023.01.447_bib46","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J\u00a0Hypertens"},{"issue":"3","key":"10.1053\/j.ajkd.2023.01.447_bib47","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ando.2016.01.007","article-title":"SFE\/SFHTA\/AFCE consensus on primary aldosteronism, part 3: confirmatory testing","volume":"77","author":"Reznik","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"issue":"5","key":"10.1053\/j.ajkd.2023.01.447_bib48","article-title":"Quantitative value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: the Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study","volume":"6","author":"Maiolino","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"10","key":"10.1053\/j.ajkd.2023.01.447_bib49","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1097\/HJH.0000000000002520","article-title":"Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J\u00a0Hypertens"},{"issue":"2","key":"10.1053\/j.ajkd.2023.01.447_bib50","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/joim.12831","article-title":"Diagnosis and treatment of primary aldosteronism: practical clinical perspectives","volume":"285","author":"Young","year":"2019","journal-title":"J\u00a0Intern Med"},{"issue":"11","key":"10.1053\/j.ajkd.2023.01.447_bib51","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1210\/jc.2018-01394","article-title":"Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism","volume":"103","author":"Stowasser","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.ajkd.2023.01.447_bib52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.117.10197","article-title":"Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study","volume":"71","author":"Song","year":"2018","journal-title":"Hypertension"},{"issue":"8","key":"10.1053\/j.ajkd.2023.01.447_bib53","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1161\/HYPERTENSIONAHA.122.19377","article-title":"Performance of confirmatory tests for diagnosing primary aldosteronism: a systematic review and meta-analysis","volume":"79","author":"Leung","year":"2022","journal-title":"Hypertension"},{"issue":"5","key":"10.1053\/j.ajkd.2023.01.447_bib54","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/cen.13582","article-title":"Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism","volume":"88","author":"Umakoshi","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1053\/j.ajkd.2023.01.447_bib55","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1210\/jc.2013-4146","article-title":"Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism","volume":"99","author":"Lim","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1053\/j.ajkd.2023.01.447_bib56","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"issue":"5","key":"10.1053\/j.ajkd.2023.01.447_bib57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archsurg.141.5.497","article-title":"Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome","volume":"141","author":"Nwariaku","year":"2006","journal-title":"Arch Surg"},{"issue":"5","key":"10.1053\/j.ajkd.2023.01.447_bib58","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1053\/j.ajkd.2023.01.447_bib59","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/HJH.0000000000002634","article-title":"The role of adrenal venous sampling and computed tomography in the management of primary aldosteronism","volume":"39","author":"Ma","year":"2021","journal-title":"J\u00a0Hypertens"},{"issue":"9","key":"10.1053\/j.ajkd.2023.01.447_bib60","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1053\/j.ajkd.2023.01.447_bib61","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2011-2830","article-title":"The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism","volume":"97","author":"Rossi","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1053\/j.ajkd.2023.01.447_bib62","doi-asserted-by":"crossref","first-page":"dgz017","DOI":"10.1210\/clinem\/dgz017","article-title":"Subtyping of primary aldosteronism in the AVIS-2 Study: assessment of selectivity and lateralization","volume":"105","author":"Rossitto","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.ajkd.2023.01.447_bib63","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"issue":"9","key":"10.1053\/j.ajkd.2023.01.447_bib64","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.01.447_bib65","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.surg.2019.05.087","article-title":"Adherence to consensus guidelines for screening of primary aldosteronism in an urban healthcare system","volume":"167","author":"Sivarajah","year":"2020","journal-title":"Surgery"},{"issue":"6","key":"10.1053\/j.ajkd.2023.01.447_bib66","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamasurg.2021.0254","article-title":"Outcomes of a specialized clinic on rates of investigation and treatment of primary aldosteronism","volume":"156","author":"Liu","year":"2021","journal-title":"JAMA Surg"},{"issue":"14","key":"10.1053\/j.ajkd.2023.01.447_bib67","article-title":"Primary aldosteronism screening rates differ with sex, race, and comorbidities","volume":"11","author":"Turcu","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"3","key":"10.1053\/j.ajkd.2023.01.447_bib68","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.119.14359","article-title":"Screening rates for primary aldosteronism in resistant hypertension: a cohort study","volume":"75","author":"Jaffe","year":"2020","journal-title":"Hypertension"},{"issue":"3","key":"10.1053\/j.ajkd.2023.01.447_bib69","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/M20-4873","article-title":"Testing for primary aldosteronism and mineralocorticoid receptor antagonist use among U.S. veterans : a retrospective cohort study","volume":"174","author":"Cohen","year":"2021","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1053\/j.ajkd.2023.01.447_bib70","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/HYPERTENSIONAHA.121.18118","article-title":"Screening rates for primary aldosteronism among individuals with hypertension plus hypokalemia: a population-based retrospective cohort study","volume":"79","author":"Hundemer","year":"2022","journal-title":"Hypertension"},{"issue":"3","key":"10.1053\/j.ajkd.2023.01.447_bib71","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1053\/j.ajkd.2009.09.014","article-title":"Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"55","author":"Muntner","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1053\/j.ajkd.2023.01.447_bib72","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jama.2020.14545","article-title":"Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018","volume":"324","author":"Muntner","year":"2020","journal-title":"JAMA"},{"issue":"13","key":"10.1053\/j.ajkd.2023.01.447_bib73","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2023.01.447_bib74","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0031-1295460","article-title":"Factors affecting the aldosterone\/renin ratio","volume":"44","author":"Stowasser","year":"2012","journal-title":"Horm Metab Res"},{"issue":"5","key":"10.1053\/j.ajkd.2023.01.447_bib75","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1210\/jcem-73-5-952","article-title":"Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism","volume":"73","author":"McKenna","year":"1991","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1053\/j.ajkd.2023.01.447_bib76","first-page":"1667","article-title":"Screening for primary aldosteronism is underutilised in patients with chronic kidney disease","volume":"35","author":"Chauhan","year":"2022","journal-title":"J\u00a0Nephrol"},{"issue":"10008","key":"10.1053\/j.ajkd.2023.01.447_bib77","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1053\/j.ajkd.2023.01.447_bib78","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-8587(18)30071-8","article-title":"Endocrine and\u00a0haemodynamic changes in resistant hypertension, and\u00a0blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies","volume":"6","author":"Williams","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.01.447_bib79","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.surg.2018.05.085","article-title":"Keeping primary aldosteronism in mind: deficiencies in screening at-risk hypertensives","volume":"165","author":"Ruhle","year":"2019","journal-title":"Surgery"},{"issue":"6","key":"10.1053\/j.ajkd.2023.01.447_bib80","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism","volume":"40","author":"Mulatero","year":"2002","journal-title":"Hypertension"},{"issue":"5","key":"10.1053\/j.ajkd.2023.01.447_bib81","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1089\/pop.2020.0186","article-title":"Health Inequalities in the use of telehealth in the United States in the lens of COVID-19","volume":"23","author":"Jaffe","year":"2020","journal-title":"Popul Health Manag"},{"issue":"11","key":"10.1053\/j.ajkd.2023.01.447_bib82","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A\u00a0prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1053\/j.ajkd.2023.01.447_bib83","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"issue":"9628","key":"10.1053\/j.ajkd.2023.01.447_bib84","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"issue":"9","key":"10.1053\/j.ajkd.2023.01.447_bib85","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/HJH.0000000000002441","article-title":"Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension","volume":"38","author":"Parasiliti-Caprino","year":"2020","journal-title":"J\u00a0Hypertens"},{"issue":"2","key":"10.1053\/j.ajkd.2023.01.447_bib86","first-page":"637","article-title":"A\u00a0survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1053\/j.ajkd.2023.01.447_bib87","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3093290","article-title":"Baseline demographic and clinical characteristics of patients with adrenal incidentaloma from a single center in China: a survey","volume":"2017","author":"Li","year":"2017","journal-title":"Int J Endocrinol"},{"issue":"3","key":"10.1053\/j.ajkd.2023.01.447_bib88","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1470320310366581","article-title":"Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism","volume":"11","author":"Di Murro","year":"2010","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"issue":"6","key":"10.1053\/j.ajkd.2023.01.447_bib89","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/HYPERTENSIONAHA.119.13833","article-title":"Primary aldosteronism and obstructive sleep apnea: a cross-sectional multi-ethnic study","volume":"74","author":"Buffolo","year":"2019","journal-title":"Hypertension"},{"issue":"4","key":"10.1053\/j.ajkd.2023.01.447_bib90","doi-asserted-by":"crossref","first-page":"629","DOI":"10.5664\/jcsm.8960","article-title":"Primary aldosteronism is highly prevalent in patients with hypertension and moderate to severe obstructive sleep apnea","volume":"17","author":"Dobrowolski","year":"2021","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1053\/j.ajkd.2023.01.447_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116774","article-title":"Primary aldosteronism in young adults with acute stroke: prevalence and clinical characteristics","volume":"413","author":"Tang","year":"2020","journal-title":"J\u00a0Neurol Sci"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2023.01.447_bib92","doi-asserted-by":"crossref","first-page":"A297","DOI":"10.1210\/jendso\/bvab048.604","article-title":"Rates of primary aldosteronism screening among high-risk populations","volume":"5","author":"Grigoryan","year":"2021","journal-title":"J\u00a0Endocr Soc"},{"issue":"3","key":"10.1053\/j.ajkd.2023.01.447_bib93","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.eprac.2021.11.085","article-title":"Screening rate for primary aldosteronism among patients with apparent treatment-resistant hypertension: retrospective analysis of current practice","volume":"28","author":"Zekarias","year":"2022","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1053\/j.ajkd.2023.01.447_bib94","first-page":"1863","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology","volume":"85","author":"Fardella","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1053\/j.ajkd.2023.01.447_bib95","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/eje.0.1500329","article-title":"Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication","volume":"150","author":"Seiler","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1053\/j.ajkd.2023.01.447_bib96","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjhyper.2005.01.002","article-title":"Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension","volume":"18","author":"Nishizaka","year":"2005","journal-title":"Am J Hypertens"},{"issue":"7","key":"10.1053\/j.ajkd.2023.01.447_bib97","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-2007-973061","article-title":"The simultaneous measurement of plasma-aldosterone-and-renin-concentration allows rapid classification of all disorders of the renin-aldosterone system","volume":"115","author":"Diederich","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"10.1053\/j.ajkd.2023.01.447_bib98","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2362.2008.02060.x","article-title":"The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism","volume":"39","author":"Willenberg","year":"2009","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"10.1053\/j.ajkd.2023.01.447_bib99","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/hr.2010.76","article-title":"Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism","volume":"33","author":"Balas","year":"2010","journal-title":"Hypertens Res"},{"issue":"1","key":"10.1053\/j.ajkd.2023.01.447_bib100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/HJH.0b013e3283656b54","article-title":"Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism","volume":"32","author":"Jansen","year":"2014","journal-title":"J\u00a0Hypertens"},{"issue":"5","key":"10.1053\/j.ajkd.2023.01.447_bib101","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","article-title":"Continuum of renin-independent aldosteronism in normotension","volume":"69","author":"Baudrand","year":"2017","journal-title":"Hypertension"},{"issue":"7","key":"10.1053\/j.ajkd.2023.01.447_bib102","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1097\/HJH.0000000000001718","article-title":"Case detection in primary aldosteronism: high-diagnostic value of the aldosterone-to-renin ratio when performed under standardized conditions","volume":"36","author":"Vorselaars","year":"2018","journal-title":"J\u00a0Hypertens"},{"issue":"9","key":"10.1053\/j.ajkd.2023.01.447_bib103","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1210\/js.2019-00145","article-title":"Diagnostic accuracy of the aldosterone-to-active renin ratio for detecting primary aldosteronism","volume":"3","author":"Pilz","year":"2019","journal-title":"J\u00a0Endocr Soc"},{"issue":"8","key":"10.1053\/j.ajkd.2023.01.447_bib104","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1210\/clinem\/dgab348","article-title":"Performance of the aldosterone to renin ratio as a screening test for primary aldosteronism","volume":"106","author":"Hung","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1053\/j.ajkd.2023.01.447_bib105","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3122\/jabfm.2020.06.190440","article-title":"Electronic health record reminder effect on hepatitis c antibody screening","volume":"33","author":"Mulhem","year":"2020","journal-title":"J\u00a0Am Board Fam Med"},{"issue":"1","key":"10.1053\/j.ajkd.2023.01.447_bib106","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12913-017-2824-9","article-title":"Use of an electronic medical record reminder improves HIV screening","volume":"18","author":"Kershaw","year":"2018","journal-title":"BMC Health Serv Res"},{"issue":"11","key":"10.1053\/j.ajkd.2023.01.447_bib107","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1158\/1055-9965.EPI-18-0448","article-title":"Electronic medical alerts increase screening for chronic hepatitis B: a randomized, double-blind, controlled trial","volume":"27","author":"Chak","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623005796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623005796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:23:47Z","timestamp":1785367427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638623005796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":107,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0272638623005796"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.01.447","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Underdiagnosis of Primary Aldosteronism: A Review of Screening and Detection","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.01.447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}